Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus
Authors:
Open Access
- 3 August 2012
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 87 (9) , 843-852
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Association of lower urinary tract symptoms and erectile dysfunction: pathophysiological aspects and implications for clinical managementInternational Journal Of Impotence Research, 2011
- Change of Erectile Function and Responsiveness to Phosphodiesterase Type 5 Inhibitors at Different Stages of Streptozotocin-Induced Diabetes in RatsThe Journal of Sexual Medicine, 2011
- Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk FactorsCurrent Bladder Dysfunction Reports, 2010
- Interrelationship of Sildenafil Treatment Effects on the Physiological and Psychosocial Aspects of Erectile Dysfunction of Mixed or Organic EtiologyThe Journal of Sexual Medicine, 2010
- Anatomy, Physiology, and Pathophysiology of Erectile DysfunctionThe Journal of Sexual Medicine, 2010
- Diabetes, Obesity and Erectile Dysfunction: Field Overview and Research PrioritiesJournal of Urology, 2009
- Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 2: Updates on Optimal Utilization for Sexual Concerns and Rare Toxicities in This Class (CME)The Journal of Sexual Medicine, 2009
- Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitusDiabetes & Vascular Disease Research, 2007
- Cardiovascular Effects of the 3 Phosphodiesterase-5 Inhibitors Approved for the Treatment of Erectile DysfunctionCirculation, 2004
- Mechanisms of action of PDE5 inhibition in erectile dysfunctionInternational Journal Of Impotence Research, 2004